semaglutide death rate Phase 3 Trial of in Metabolic Dysfunction–Associated Steatohepatitis Semaglutide Reduces Cardiovascular and COVID

Accumulated evidence suggests that long term treatment with GLP-1 receptor agonist is associated with a reduction in measured glomerular filtration rate (GFR), preservation of renal function and/or a decrease in the incidence of cardiovascular events

Branded Price: ~$1,000 $1,300 per month (cash pay)

P., Fu, W

The compound's ability to restore tissue homeostasis and reverse age-related functional decline in animal models provides direct evidence for the role of senescent cells in aging processes, while its applications in cancer research offer insights into senescence mechanisms in disease progression and administration resistance

GLP-1 Receptor Agonists and Eating Disorders Cause for Concern | New England Journal of Medicine